Research Article

Thiostrepton-Nanomedicine, a TLR9 Inhibitor, Attenuates Sepsis-Induced Inflammation in Mice

Figure 1

Experimental groups and survival study of mice with CLP-induced sepsis. (a, b) C57BL/6 mice (12 per group) underwent cecal ligation and puncture (CLP) or SHAM surgery (time 0). At 6 hr, CLP mice were either treated with empty micelles (SSM) or 20 mg/kg thiostrepton nanomedicine (TST-SSM) intraperitoneally and monitored for survival up to 7 days (168 hr). Survival rates were compared using the log-rank (Mantel-cox) test. was considered statistically significant.
(a)
(b)